Parkedale Turns To Consultants After FDA Halts Fluogen Production
Executive Summary
Parkedale Pharmaceuticals is drawing on advice from regulatory consultants The Biologics Consulting Group and regulatory legal counsel Arnold and Porter in "evaluating strategies pertaining to Fluogen," the company said.
You may also be interested in...
King Fluogen Discontinued; Flu Vaccine Would Have Been Unavailable In 2000
King Pharmaceuticals will discontinue Fluogen following receipt of a Sept. 27 FDA letter concerning the flu vaccine.
King Fluogen Discontinued; Flu Vaccine Would Have Been Unavailable In 2000
King Pharmaceuticals will discontinue Fluogen following receipt of a Sept. 27 FDA letter concerning the flu vaccine.
Powderject Moves Into Marketing Phase Via Medeva Vaccines Acquisition
Powderject's acquisition of Medeva's vaccines business moves the company from the research phase into the marketing of six products, one of which is sold in the U.S.